Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility
RESCU
1 other identifier
observational
403
1 country
8
Brief Summary
The purpose of this multicenter study is to assess the impact of SSO2 treatment on clinical outcomes and left ventricular function in patients following acute ST-segment elevation myocardial infarction (STEMI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2023
Shorter than P25 for all trials
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 28, 2023
CompletedFirst Posted
Study publicly available on registry
July 18, 2023
CompletedStudy Start
First participant enrolled
July 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedApril 4, 2024
April 1, 2024
7 months
June 28, 2023
April 3, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change of Left Ventricular Ejection Fraction
Between group comparison
Baseline to 3 months
Rate of Cardiovascular related Hospitalizations
Between group comparison
Through study completion, an average of 1 year
Study Arms (8)
Minneapolis Heart Institute
The Feinstein Institutes for Medical Research
NCH Baker Downtown Hospital
OhioHealth Research Institute
Baptist Health Baptist Hospital
St. Mary's Medical Center
Corewell Health William Beaumont University Hospital - Research Institute
University of Chicago Medicine
Eligibility Criteria
This is a multicenter, retrospective case-control study which will collect data from all STEMI patients who received SSO2 treatment at participating centers, along with up to 3 matched control patients who did not receive SSO2 treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Baptist Hospital of Miami, Inc and Its Miami Cardiac and Vascular Institute
Miami, Florida, 33176, United States
NCH Healthcare System
Naples, Florida, 34102, United States
Oakwood Healthcare, Inc
Dearborn, Michigan, 48124, United States
Minneapolis Heart Institute Foundation
Minneapolis, Minnesota, 55407, United States
Northwell Health, Inc
Great Neck, New York, 11021, United States
OhioHealth Research Institute
Columbus, Ohio, 43214, United States
Avita Health
Galion, Ohio, 44833, United States
St. Mary's Medical Center
Huntington, West Virginia, 25702, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 28, 2023
First Posted
July 18, 2023
Study Start
July 31, 2023
Primary Completion
February 28, 2024
Study Completion
March 31, 2024
Last Updated
April 4, 2024
Record last verified: 2024-04